Udine Wealth Management Inc. Has $2.77 Million Stake in Oscar Health, Inc. $OSCR

Udine Wealth Management Inc. lifted its stake in Oscar Health, Inc. (NYSE:OSCR) by 138.4% in the third quarter, Holdings Channel.com reports. The firm owned 146,555 shares of the company’s stock after acquiring an additional 85,083 shares during the quarter. Oscar Health comprises 1.3% of Udine Wealth Management Inc.’s portfolio, making the stock its 20th largest holding. Udine Wealth Management Inc.’s holdings in Oscar Health were worth $2,774,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also made changes to their positions in the stock. Straightline Group LLC increased its stake in Oscar Health by 3.7% in the 2nd quarter. Straightline Group LLC now owns 18,082 shares of the company’s stock valued at $388,000 after buying an additional 640 shares during the period. Wealthspire Advisors LLC grew its holdings in shares of Oscar Health by 6.7% during the 2nd quarter. Wealthspire Advisors LLC now owns 11,117 shares of the company’s stock valued at $238,000 after acquiring an additional 700 shares in the last quarter. PNC Financial Services Group Inc. increased its stake in shares of Oscar Health by 14.4% in the second quarter. PNC Financial Services Group Inc. now owns 7,140 shares of the company’s stock worth $153,000 after acquiring an additional 900 shares during the last quarter. Focus Partners Wealth increased its stake in shares of Oscar Health by 1.8% in the first quarter. Focus Partners Wealth now owns 55,158 shares of the company’s stock worth $723,000 after acquiring an additional 949 shares during the last quarter. Finally, LRI Investments LLC raised its holdings in shares of Oscar Health by 377.9% during the second quarter. LRI Investments LLC now owns 1,233 shares of the company’s stock worth $26,000 after acquiring an additional 975 shares in the last quarter. 75.70% of the stock is currently owned by institutional investors and hedge funds.

Oscar Health Stock Performance

OSCR opened at $16.71 on Thursday. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.92 and a current ratio of 0.92. The company has a market cap of $4.42 billion, a PE ratio of -14.92 and a beta of 1.90. The stock has a 50-day moving average of $15.80 and a 200-day moving average of $16.88. Oscar Health, Inc. has a 52-week low of $11.20 and a 52-week high of $23.80.

Oscar Health (NYSE:OSCR) last issued its quarterly earnings data on Thursday, November 6th. The company reported ($0.53) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.55) by $0.02. The business had revenue of $2.93 billion for the quarter, compared to the consensus estimate of $3.09 billion. Oscar Health had a negative return on equity of 21.50% and a negative net margin of 2.16%.The firm’s revenue was up 23.2% compared to the same quarter last year. During the same period last year, the business earned ($0.22) EPS. As a group, equities research analysts forecast that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on OSCR. Wall Street Zen downgraded Oscar Health from a “hold” rating to a “sell” rating in a research note on Saturday, December 6th. Barclays set a $18.00 price target on Oscar Health and gave the company an “equal weight” rating in a research note on Monday, January 5th. UBS Group raised Oscar Health from a “sell” rating to a “neutral” rating and boosted their price target for the company from $12.00 to $17.00 in a research note on Friday, January 9th. Zacks Research raised shares of Oscar Health from a “strong sell” rating to a “hold” rating in a research report on Monday, October 13th. Finally, Wells Fargo & Company reduced their target price on shares of Oscar Health from $14.00 to $11.00 and set an “underweight” rating for the company in a research note on Thursday, November 13th. One investment analyst has rated the stock with a Buy rating, eight have assigned a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Reduce” and a consensus target price of $17.00.

Insider Activity

In related news, insider Mario Schlosser sold 286,182 shares of the firm’s stock in a transaction on Tuesday, November 11th. The shares were sold at an average price of $15.27, for a total value of $4,369,999.14. Following the transaction, the insider directly owned 501,148 shares in the company, valued at approximately $7,652,529.96. This trade represents a 36.35% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, insider Adam Mcananey sold 1,852 shares of the business’s stock in a transaction on Tuesday, December 2nd. The stock was sold at an average price of $16.59, for a total transaction of $30,724.68. Following the transaction, the insider directly owned 179,241 shares of the company’s stock, valued at approximately $2,973,608.19. This represents a 1.02% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders sold 483,307 shares of company stock worth $7,635,300. 24.39% of the stock is owned by company insiders.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.